Back to UBS Group AG UBS Group AG

ADXNADXN
4 quarters

Position history for UBS Group AGUBS Group AG's holdings in ADDEX THERAPEUTICS LTD

UBS Group AG holds 47 shares of ADXN (ADDEX THERAPEUTICS LTD), worth $268 as of 2026-Q2. This is a new position.

Current Value

$268

Current Shares

47

Total Value Change

+$259

Total Shares Change

+46

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
47
-
$2680.0%$5.70
17
2026-Q1
Exited
0
-100.0%
$00.0%$7.07
0
2025-Q4
Increased
156
+155x
$1,2040.0%$7.74
12
2025-Q3
New
1
-
$90.0%$8.94
17

Other major holders of ADXN: CITADEL ADVISORS LLC, MORGAN STANLEY

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used